Latest S-1 registration statements

DUKE Robotics Corp. has filed an amended S-1 registration statement detailing its plan for a firm commitment underwritten public offering of units and the potential resale of shares by selling stockholders, aiming for a Nasdaq Capital Market listing.

Iron Dome Acquisition I Corp. has filed an amended S-1 registration statement detailing its proposed IPO of 15,000,000 units, each consisting of one Class A ordinary share and one-half of a redeemable warrant.

Enhanced Group Inc. has filed a registration statement for the resale of up to 61,704,115 shares of Class A common stock by selling securityholders.

Neptune Insurance Holdings Inc. has filed an S-1 registration statement with the SEC, detailing an offering of 8,355,615 shares of Class A common stock by selling stockholders.

Virtuix Holdings Inc. has filed a registration statement with the SEC for the resale of up to 25,307,961 shares of its Class A common stock by selling stockholders.

Rhinebeck Bancorp, Inc. is proceeding with its conversion from a mutual holding company structure to a fully public stock holding company, including a stock offering of up to 8,912,500 shares at $10.00 per share.

Idaho Copper Corporation is filing an S-1/A amendment to register 2,793,300 shares of common stock and accompanying warrants for a firm commitment public offering.

Cerebras Systems Inc. has filed an S-1/A amendment detailing its 2026 Employee Stock Purchase Plan, outlining provisions for employee stock ownership and participation in the company's growth.

Vaxart, Inc. has registered up to 32.9 million shares of common stock for resale by Lincoln Park Capital Fund, LLC to support its ongoing clinical development programs.

Suncrete, Inc. (RMIX) announced the successful completion of its business combination with Haymaker Acquisition Corp. 4, positioning the ready-mix concrete logistics and distribution platform for expansion across the Sunbelt region.

Akari Therapeutics, PLC has filed a registration statement for a best-efforts offering of ADSs and warrants to raise approximately $7.5 million for research and development.

Veea Inc. has filed an amended registration statement for the resale of up to 15,306,748 shares of common stock by selling stockholders.

Algorhythm Holdings, Inc. has filed a registration statement for the potential resale of up to 10,000,000 shares of common stock by Streeterville Capital, LLC.

Smith Micro Software registers 18.2 million shares for potential resale by selling stockholders following recent debt and warrant issuances.

Odyssey Therapeutics has filed a Rule 462(b) registration statement to increase its common stock offering by 2,599,000 shares.

Eloxx Pharmaceuticals, a clinical-stage biopharmaceutical company, is seeking to raise capital and uplist its common stock to the Nasdaq Capital Market to fund the advancement of its lead product candidate, exaluren, for rare kidney diseases.

Veri Medtech Holdings, Inc. is filing an amendment to its S-1 registration statement to offer up to 3,750,000 shares of common stock at $4.00 per share.

Onconetix, Inc. has filed an amendment to its Form S-1 registration statement, primarily to include an exhibit containing a legal opinion regarding the securities being registered.

SeaStar Medical Holding Corporation has filed an S-1/A amendment to register up to 2,000,000 shares of common stock for resale by Lincoln Park Capital Fund, LLC.

SHF Holdings, Inc. has filed a registration statement to facilitate the potential resale of 22.6 million shares of its Class A common stock by existing stockholders.

Aperture AC, a blank check company targeting the digital assets industry, has filed an amended S-1 registration statement with the SEC, detailing its proposed $90 million initial public offering.

Merlin Inc. has filed a registration statement with the SEC for the resale of up to 13,336,000 shares of its common stock by a selling stockholder.

Acurx Pharmaceuticals, Inc. has filed a Form S-1 registration statement to allow Lincoln Park Capital Fund, LLC to resell up to 1,300,000 shares of common stock.

Acurx Pharmaceuticals, Inc. has filed a Form S-1 with the SEC to register for resale up to 1,650,170 shares of its common stock issuable upon exercise of Series H warrants.

Odyssey Therapeutics, Inc. has filed an amendment to its S-1 registration statement, detailing plans for an initial public offering of 13,240,000 shares of common stock with an estimated price range of $16.00 to $18.00 per share, aiming for a Nasdaq listing under the symbol ODTX.

Cerebras Systems Inc. has filed an S-1/A amendment with the SEC, detailing plans for its initial public offering, aiming to raise capital and list on the Nasdaq under the ticker CBRS.

Liftoff Mobile, Inc. has filed an S-1/A amendment with the SEC, detailing its initial public offering plans and aiming for a listing on the Nasdaq Global Select Market under the ticker symbol LFTO.

CEL-SCI Corporation has filed an amendment to its registration statement to raise approximately $13.7 million through a best-efforts offering of common stock and pre-funded warrants.

Picard Medical, Inc. is offering up to 21.1 million shares of common stock and associated warrants to raise approximately $9.1 million, facing significant net losses and a going concern doubt.

Profusa, Inc. has filed an amended registration statement to facilitate the resale of up to 179.3 million shares of common stock by selling stockholders.